Disc Medicine
IRON
#4353
Rank
A$3.06 B
Marketcap
$103.16
Share price
2.46%
Change (1 day)
20.31%
Change (1 year)

P/E ratio for Disc Medicine (IRON)

P/E ratio as of December 2024 (TTM): -16.1

According to Disc Medicine's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.0941. At the end of 2022 the company had a P/E ratio of -0.8712.

P/E ratio history for Disc Medicine from 2020 to 2023

2021202220232024-80-60-40-20200companiesmarketcap.com

PE ratio at the end of each year

Year P/E ratio Change
2022-0.8712-91.53%
2021-10.3-88.08%
2020-86.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.